T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report released on Wednesday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

TTOO opened at $0.22 on Wednesday. The stock’s 50 day simple moving average is $0.39 and its 200 day simple moving average is $1.84. T2 Biosystems has a 1 year low of $0.22 and a 1 year high of $6.95.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.